Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXAFA: Apixaban vs vitamin K antagonists during atrial fibrillation catheter ablation
2014-002442-45Phase 4Completed
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of apixaban in Atrial fibrillation (AFib) (2 arms), sponsored by Kompetenznetz Vorhofflimmern. Primary endpoint: Primary composite safety outcome. Started Sep 2014; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2014-002442-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002442-45.